CXCR5 and myeloid sarcoma: As depicted in Figure 4, CXCR5+ circulating regulatory T cells were significantly increased in MS patients carrying the rs10892307 minor allele, that is, the MS-protective allele, compared with minor allele non-carriers (p = 0.04).